...
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery
【24h】

Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery

机译:离子胶凝法制备胶原蛋白肽官能化壳聚糖纳米粒子:一种有效的癌药物封装和释放癌症药物递送的有效载体系统

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, nanoparticles (NPs) based on biopolymers or peptides are gaining popularity for the encapsulation and release of drug molecules, especially for cancer therapy, due to their ability for targeted and controlled release. The use of collagen peptide (CP) for the preparation of chitosan (CN) NPs is especially interesting as it results in NPs that are stable under physiological conditions. In this work, mono-dispersed pH responsive CPCN NPs of about 100 nm were prepared via ionic gelation method by simple and mild co-precipitation of CN and CP. Investigation of NPs with Fourier transform infra-red (FTIR) spectroscopy and dynamic light scattering (DLS) measurements reveals that hydrogen bonding and electrostatic interactions are believed to be major driving forces for NP formation and drug encapsulation, respectively. Scanning electron microscopic (SEM) investigations show that hard and fine CPCN NPs transform to soft and bigger gel like particles as a function of collagen concentration. The unique "polymeric gel" structure of NPs showed high encapsulation efficiency towards doxorubicin hydrochloride (DOX) as well as pH controlled release. Anti-proliferative and cell viability analysis revealed that DOX loaded NPs showed excellent anti-proliferative characteristics against HeLa cells with favorable biocompatibility against normal cells. Such NPs have high potential for use as smart drug delivery carriers in advanced cancer therapy. (C) 2016 Elsevier B.V. All rights reserved.
机译:近年来,基于生物聚合物或肽的纳米颗粒(NPS)是由于其靶向和控制释放的能力而获得了药物分子的封装和释放的普及,特别是对于癌症治疗。使用胶原蛋白肽(CP)用于制备壳聚糖(CN)NPS特别有趣,因为它导致在生理条件下稳定的NPS。在这项工作中,通过CN和Cp的简单和温和的共沉淀,通过离子凝胶化方法制备约100nm的单分散的pH响应CPCN NP。具有傅里叶变换红外(FTIR)光谱和动态光散射(DLS)测量的NPS的研究表明,据信氢键和静电相互作用分别是NP形成和药物包封的主要驱动力。扫描电子显微镜(SEM)调查表明,作为胶原浓度的函数,硬质和精细的CPCN NPS变换为柔软和更大的凝胶等颗粒。 NPS的独特的“聚合物凝胶”结构对盐酸甲霉素(DOX)以及pH控制释放表示高封装效率。抗增殖性和细胞活力分析显示,DOX负载的NPS对Hela细胞的优异的抗增殖特性具有良好的生物相容性,对正常细胞具有良好的生物相容性。这种NPS具有高潜力的用途,可用作晚期癌症治疗中的智能药物递送载体。 (c)2016年Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号